Innovative Digital Therapy Oncomfort's core offering, Digital Sedation, leverages virtual reality and clinical hypnotherapy to provide a non-pharmacological alternative for pain and anxiety management during medical procedures, presenting a compelling solution for healthcare providers seeking to enhance patient comfort and safety.

Growing Market Presence With over 30,000 patients treated across Europe and partnerships with distributors like Vygon SA, Oncomfort demonstrates expanding market reach and increasing adoption of digital sedation techniques, ideal for targeting clinics, hospitals, and medical centers interested in innovative patient care.

Recent Acquisition Potential The recent acquisition of Oncomfort by Hypnovr suggests an industry shift towards consolidating digital therapeutic solutions, opening opportunities to offer bundled services or complementary technologies within the digital health and VR therapy sectors.

Funding and Validation Having secured nearly $10 million in Series A funding and receiving multiple innovation awards, Oncomfort's strong financial backing and industry recognition position it well for scaling sales efforts and penetrating larger healthcare markets.

Targeted Customer Segments Given its success in the pediatric and adult treatment settings for conditions like cancer and heart disease, there are significant sales opportunities within specialty clinics, treatment centers, and hospitals seeking to incorporate digital sedation as part of comprehensive patient care protocols.